Linde plc (LIN) Institutional Ownership & Insider Trading

2,310 institutions reported holding Linde plc shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 9 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LINLinde plcFollow LIN — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 234.6B
P/E TTM: 32.8
Dividend yield: 1.2%
52-week: —
Next earnings: 29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

2,310 institutions held 85.3% of the shares. Across filers that reported both quarters, shares held changed -0.5%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	2,310	393	-0.5%	836	158	636	85
Mar 26	2,225	378	+0.6%	813	242	579	105
Dec 25	2,057	379	-3.0%	599	116	755	175
Sep 25	2,051	382	+1.3%	694	106	548	73
Jun 25	2,036	383	-0.8%	719	104	561	65
Mar 25	1,993	378	-1.0%	694	145	575	86
Dec 24	1,928	388	-2.5%	586	91	554	107
Sep 24	1,846	379	-2.0%	581	121	508	59

Linde plc — questions

Who owns Linde plc stock?: 2,310 institutions reported Linde plc shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.1%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), STATE STREET CORP (4.4%).
Are Linde plc insiders buying or selling?: 9 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Linde plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.